London Daily

Focus on the big picture.
Friday, Apr 03, 2026

Oxford-AstraZeneca Covid jab safe, insists Hancock

Oxford-AstraZeneca Covid jab safe, insists Hancock

The Oxford-AstraZeneca Covid vaccine is safe, the health secretary has said, after some European nations paused its use amid concern over blood clots.

Matt Hancock urged people to "listen to the regulators" and to "get the jab" as soon as they got the opportunity.

Some 13 countries have suspended use of the vaccine while they seek further clarification on its safety.

But the UK's medicines watchdog, the MHRA, has said that evidence "does not suggest" the jab causes clots.

The EU's regulator, the European Medicines Agency (EMA), is expected to release the findings of its investigation into cases of blood clots in vaccinated people on Thursday.

However, it said previously that it was still "firmly convinced" the benefits of the Oxford-AstraZeneca vaccine outweighed the risks and there was "no indication" the jab causes blood clots.

About 17 million people across the EU and the UK have received a dose of the vaccine, with fewer than 40 cases of blood clots reported as of last week, the manufacturer AstraZeneca said.

It said the number of cases of blood clots reported was lower than the hundreds of cases that would be expected among the general population.

In a bid to reassure the British public, Mr Hancock stressed that the MHRA, the World Health Organization and the European Medicines Agency all believed the vaccine was safe.

"We keep the effects of these vaccines under review all the time and we know that the Oxford-AstraZeneca vaccine is saving lives in the UK right now so if you get the call, get the jab," he said.

Asked if there had been evidence of people declining the jab after the European suspensions, the health secretary said there were still "huge numbers of people vaccinated every day" and that "enthusiasm for getting the vaccine is incredibly strong".


Downing Street has also defended the safety of the vaccine, with the PM's official spokesman insisting that Boris Johnson would be happy to take it when it came to his turn.

Meanwhile, the Duchess of Cornwall revealed on Tuesday that she had received the Oxford-AstraZeneca jab earlier this year.

Speaking during a visit to a pop-up vaccination centre in London with the Prince of Wales, Camilla joked that it "didn't matter" which jab she was given because "I hate injections so much".

The Duchess of Cornwall revealed she received the Oxford-AstraZeneca jab during a visit to a vaccination centre on Tuesday
It was announced in mid-February that Prince Charles, 72, and the duchess, 73, had received their first Covid jabs. Their ages meant they were included in the fourth priority group for the rollout of the vaccine.

The latest government figures show that 24,839,906 first doses of a Covid vaccine have now been given in the UK, with some 1,663,646 people receiving a second dose.

Countries across Europe are seeking further clarity on the jab's safety, amid criticism of their decision to suspend its use.

Denmark was first to pause its use of the vaccine, followed by Norway and Iceland. Germany, France, Italy, Cyprus, Spain, Latvia and Sweden are the latest to follow suit.

Germany, France and Italy have said they are awaiting the outcome of the EMA investigation.

They said they had opted to pause their use of the drug as a "precautionary measure".

Other countries, including Austria, have halted the use of certain batches of the jab, while Belgium, Poland, the Czech Republic and Ukraine said they would continue to administer it.

Dr Phil Bryan, vaccines safety lead at the MHRA, said that people "should still go and get their Covid-19 vaccine when asked to do so".

"We are closely reviewing reports but given the large number of doses administered, and the frequency at which blood clots can occur naturally, the evidence available does not suggest the vaccine is the cause."

The WHO, which is also investigating the reports, says there is no evidence that the clots were linked to the vaccine and it has urged countries not to pause their vaccination programmes.

Prof Jeremy Brown, a member of the UK government's Joint Committee on Vaccination and Immunisation, said concerns about blood clots were "overblown" as they were unlikely to be linked to the jab.

He told BBC Radio 4's Today programme pausing its use would cause more illness and deaths than would be prevented "by the unlikely situation that there's an increased risk of a very rare event occurring as a consequence of the vaccine".

Sir Kent Woods, former chief executive of the MHRA and former chair of the EMA, told BBC Breakfast there would have been a "denting of public confidence because of the disorderly situation in Europe" and by suspending the use of the jab countries were "increasing the risk to the population".

Dr Jess Harvey, a GP in Shropshire, said she had received several calls from patients concerned about the possibility of blood clots linked to the vaccine.

She said she had not had any appointments cancelled yet but was worried about no-shows.

Meanwhile, Public Health England said on Tuesday that it was investigating a new coronavirus variant previously reported by the Philippines, after two cases were identified in England.

It said one case was linked with international travel, while the other was still under investigation.

PHE also said that two cases of the P.1 variant of concern first found in Brazil had been identified in England - with one in the West Midlands and another in Haringey, London.

This variant has a mutation - known as E484 - that means it can escape some of the immune response, which may mean vaccines work less effectively against it.

Both cases were linked with international travel to Brazil, PHE said, and bring the total number of UK cases of the variant to 12.


Health Secretary Matt Hancock: "If you get the call, get the jab"


Newsletter

Related Articles

0:00
0:00
Close
Trump’s Strategic Pressure on UK Seen as Push for Stronger Alignment and Fairer Terms
UK Focuses on Trade Finance to Secure Critical Materials for Defence and Energy Sectors
Majority of UK Businesses Hit by Middle East Conflict While Confidence Holds Firm
UK Royal Navy Faces Renewed Scrutiny as Debate Intensifies Over Capability and Readiness
Reform UK Faces Mounting Distractions as Policy Agenda Struggles to Gain Traction
Investigation Launched Into Northern Cyprus IVF Clinics After UK Families Receive Incorrect Sperm
International Meeting Issues Unified Call to Safeguard Navigation Through Strait of Hormuz
Potential Strait of Hormuz Closure Raises Concerns Over UK Food and Medicine Supply Chains
UK Leads Coalition of Over Forty Nations Urging Iran to Reopen Strait of Hormuz
UK Secures Tariff-Free Access for Medicines in Landmark US Pharma Trade Agreement
King Charles III Invited to Address Joint Session of U.S. Congress in Rare Diplomatic Honor
Debate Grows Over Whether Expanded North Sea Drilling Can Reduce UK Energy Bills
UK Faces Heightened Risk of Jet Fuel Shortages, Airline Chief Warns
UK Ends Police Investigations into Lawful Social Media Posts After Review Finds Overreach
Abramovich Moves to Establish Charity for Frozen Chelsea Sale Proceeds Amid UK Dispute
Starmer Reaffirms NATO Commitment While Responding to Trump’s Strategic Critique
UK Aid Reductions Raise Fears of Severe Human Impact Across Parts of Africa
UK Signals Renewed Push for EU Cooperation as Iran Conflict Reshapes Security Landscape
Bank of England Signals Caution as Bailey Advises Markets Against Expecting Rate Hikes
UK to Convene Global Coalition to Restore Shipping Through Strait of Hormuz
Trump Signals Possible NATO Reassessment, Emphasizes Stronger U.S. Strategic Autonomy
Australia Joins British-Led Efforts to Reopen Strait of Hormuz Amid Escalating Tensions
King Charles Plans US State Visit as UK Strengthens Ties with Trump Leadership
UK Regulator Launches Investigation Into Microsoft’s Business Software Practices
Kanye West Set for High-Profile Return to UK Stage at Wireless Festival
Trump Presses Europe to Strengthen Commitment as Iran Conflict Escalates
UK to Deploy Additional Troops to Middle East Amid Rising Regional Tensions
UK Authorities Face Claims of Heavy-Handed Measures in Monitoring Released Pro-Palestine Activists
Trump Calls on UK to Secure Its Own Energy as Iran Conflict Intensifies
Nigel Farage Declines Invitation to UK Conservative Conference Led by Liz Truss
Trump Warns Allies to Take Responsibility as Rift Deepens with UK and France Over Iran Conflict
How Britain’s Prime Minister Controls U.S. Bomber Access in Escalating Iran Conflict
Trump Urges Allies to Secure Their Own Oil Supplies as Hormuz Crisis Disrupts Global Energy
Russia Expels British Diplomat as UK Pushes Back Against Pressure
White House App Faces Scrutiny After Claims of Continuous User Location Tracking
BBC Faces Scrutiny Over Allegations of Paid Content Linked to Saudi Arabia
UK-France Coastal Patrol Agreement Nears Breakdown Amid Migration Pressures
UK Police Detain Pro-Palestine Activist Again Weeks After Bail Release
FTSE 100 Advances as Energy and Mining Shares Gain Amid Middle East Tensions
Eli Lilly Seeks UK Pricing Deal to Unlock Renewed Pharmaceutical Investment
Three Arrested in UK After Massive Cocaine Haul Discovered Hidden in Banana Shipment
UK Fuel Prices Poised for Further Surge Amid Global Energy Pressures
Apple Subsidiary Penalized by UK Authorities for Breach of Moscow Sanctions
Western Allies Intensify Coordinated Sanctions Strategy Against Russia
UK Lawmakers Face Criticism Over Renewed Push for Social Media Restrictions
Starmer Signals UK Crackdown on Addictive Social Media Features
Rising Costs Push One in Five UK Hospitality Businesses to the Brink of Closure
Man Arrested on Suspicion of Attempted Murder After Car Strikes Pedestrians in UK, Injuring Seven
Escalating Conflict Involving Iran Tightens Fiscal Pressures and Highlights UK Economic Vulnerabilities
UK Moves to Confront Russian ‘Shadow Fleet’ Operating in Its Waters
×